Additionally, patients with high ICAFBS score showed enhanced expression of multiple immune checkpoint molecules, including PD‐1, PD‐L1, and CTLA‐4, indicating a tumor milieu prone to immune evasion. The gene discussed is CD274; the disease is neoplasm.